Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Monday's Pre-Market Session

Author: Benzinga Insights | March 25, 2024 09:05am

Gainers

  • Landos Biopharma (NASDAQ:LABP) shares moved upwards by 181.6% to $22.05 during Monday's pre-market session. The market value of their outstanding shares is at $68.7 million. As per the press release, Q4 earnings came out 2 days ago.
  • Altamira Therapeutics (NASDAQ:CYTO) shares rose 49.71% to $2.59. The market value of their outstanding shares is at $4.7 million.
  • Esperion Therapeutics (NASDAQ:ESPR) stock increased by 21.83% to $2.79. The company's market cap stands at $516.2 million.
  • Salarius Pharmaceuticals (NASDAQ:SLRX) shares moved upwards by 21.66% to $0.75. The company's market cap stands at $2.9 million. As per the news, the Q4 earnings report came out yesterday.
  • Neuronetics (NASDAQ:STIM) stock increased by 18.19% to $5.0. The market value of their outstanding shares is at $148.7 million.
  • Nkarta (NASDAQ:NKTX) stock rose 17.93% to $10.52. The market value of their outstanding shares is at $516.2 million. As per the news, the Q4 earnings report came out 2 days ago.

Losers

  • SINTX Techs (NASDAQ:SINT) stock declined by 46.5% to $0.05 during Monday's pre-market session.
  • Akanda (NASDAQ:AKAN) stock declined by 32.2% to $0.17. The market value of their outstanding shares is at $1.4 million.
  • Trxade Health (NASDAQ:MEDS) stock declined by 30.42% to $16.75. The market value of their outstanding shares is at $20.1 million.
  • Nuvation Bio (NYSE:NUVB) shares declined by 18.62% to $1.88. The company's market cap stands at $411.8 million.
  • Yield10 Bioscience (NASDAQ:YTEN) stock fell 11.82% to $0.33. The market value of their outstanding shares is at $3.9 million.
  • Virios Therapeutics (NASDAQ:VIRI) stock declined by 9.27% to $0.41. The market value of their outstanding shares is at $7.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKAN CYTO ESPR LABP MEDS NKTX NUVB SINT SLRX STIM VIRI YTEN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist